451 related articles for article (PubMed ID: 24732238)
1. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
[TBL] [Abstract][Full Text] [Related]
2. Acute phase response impairs host defense against Pseudomonas aeruginosa pneumonia in mice.
Renckens R; van Westerloo DJ; Roelofs JJ; Pater JM; Schultz MJ; Florquin S; van der Poll T
Crit Care Med; 2008 Feb; 36(2):580-7. PubMed ID: 18091542
[TBL] [Abstract][Full Text] [Related]
3. Depletion of natural CD4+CD25+ T regulatory cells with anti-CD25 antibody does not change the course of Pseudomonas aeruginosa-induced acute lung infection in mice.
Carrigan SO; Yang YJ; Issekutz T; Forward N; Hoskin D; Johnston B; Lin TJ
Immunobiology; 2009; 214(3):211-22. PubMed ID: 19215803
[TBL] [Abstract][Full Text] [Related]
4. Cytokine and surface receptor diversity of NK cells in resistant C3H/HeN and susceptible BALB/c mice with chronic Pseudomonas aeruginosa lung infection.
Calum H; Moser C; Jensen PØ; Shirai R; Høiby N
APMIS; 2003 Sep; 111(9):891-7. PubMed ID: 14510646
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy With Antiprogrammed Cell Death 1 Antibody Improves Outcome in a Mouse Model of Spinal Cord Injury Followed by Staphylococcus aureus Pneumonia.
Ruggeri T; Jacqueline C; Ambrosi X; Broquet A; Desfrançois J; Roquilly A; Altare F; Asehnoune K
Crit Care Med; 2019 Jan; 47(1):e28-e35. PubMed ID: 30303841
[TBL] [Abstract][Full Text] [Related]
6. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
McClellan SA; Zhang Y; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
[TBL] [Abstract][Full Text] [Related]
7. Enhanced splenic bacterial clearance and neutrophilia in anti-NK1.1-treated mice infected with Pseudomonas aeruginosa.
Newton DW; Runnels HA; Kearns RJ
Nat Immun; 1992; 11(6):335-44. PubMed ID: 1477496
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response.
Jacqueline C; Roquilly A; Desessard C; Boutoille D; Broquet A; Le Mabecque V; Amador G; Potel G; Caillon J; Asehnoune K
J Antimicrob Chemother; 2013 Jan; 68(1):177-83. PubMed ID: 22941899
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
Pène F; Grimaldi D; Zuber B; Sauneuf B; Rousseau C; El Hachem C; Martin C; Belaïdouni N; Balloy V; Mira JP; Chiche JD
J Infect Dis; 2012 Sep; 206(6):932-42. PubMed ID: 22782952
[TBL] [Abstract][Full Text] [Related]
10. NKT cells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa.
Kinjo T; Nakamatsu M; Nakasone C; Yamamoto N; Kinjo Y; Miyagi K; Uezu K; Nakamura K; Higa F; Tateyama M; Takeda K; Nakayama T; Taniguchi M; Kaku M; Fujita J; Kawakami K
Microbes Infect; 2006 Oct; 8(12-13):2679-85. PubMed ID: 16979364
[TBL] [Abstract][Full Text] [Related]
11. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells in sepsis: detrimental role for final outcome.
Giamarellos-Bourboulis EJ
Crit Care Med; 2014 Jun; 42(6):1579-80. PubMed ID: 24836809
[No Abstract] [Full Text] [Related]
13. IL-27 controls sepsis-induced impairment of lung antibacterial host defence.
Cao J; Xu F; Lin S; Song Z; Zhang L; Luo P; Xu H; Li D; Zheng K; Ren G; Yin Y
Thorax; 2014 Oct; 69(10):926-37. PubMed ID: 25074706
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells.
Roquilly A; Broquet A; Jacqueline C; Gautreau L; Segain JP; de Coppet P; Caillon J; Altare F; Josien R; Asehnoune K
Eur Respir J; 2013 Nov; 42(5):1365-78. PubMed ID: 23314895
[TBL] [Abstract][Full Text] [Related]
15. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection.
Wölbeling F; Munder A; Kerber-Momot T; Neumann D; Hennig C; Hansen G; Tümmler B; Baumann U
Immunobiology; 2011 Aug; 216(8):901-8. PubMed ID: 21497410
[TBL] [Abstract][Full Text] [Related]
16. Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice.
O'Sullivan R; Carrigan SO; Marshall JS; Lin TJ
Immunobiology; 2008; 213(6):469-79. PubMed ID: 18514749
[TBL] [Abstract][Full Text] [Related]
17. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection.
Lighvani S; Huang X; Trivedi PP; Swanborg RH; Hazlett LD
Eur J Immunol; 2005 May; 35(5):1567-75. PubMed ID: 15832292
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.
Faure E; Mear JB; Faure K; Normand S; Couturier-Maillard A; Grandjean T; Balloy V; Ryffel B; Dessein R; Chignard M; Uyttenhove C; Guery B; Gosset P; Chamaillard M; Kipnis E
Am J Respir Crit Care Med; 2014 Apr; 189(7):799-811. PubMed ID: 24555512
[TBL] [Abstract][Full Text] [Related]
19. Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa.
Seki M; Higashiyama Y; Tomono K; Yanagihara K; Ohno H; Kaneko Y; Izumikawa K; Miyazaki Y; Hirakata Y; Mizuta Y; Tashiro T; Kohno S
Clin Exp Immunol; 2004 Jul; 137(1):35-40. PubMed ID: 15196241
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage.
Roquilly A; Broquet A; Jacqueline C; Masson D; Segain JP; Braudeau C; Vourc'h M; Caillon J; Altare F; Josien R; Retière C; Villadangos J; Asehnoune K
Crit Care Med; 2014 Dec; 42(12):e752-61. PubMed ID: 25289930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
